Australia markets open in 4 hours 43 minutes

TRxADE HEALTH, Inc. (MEDS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.30+0.24 (+4.05%)
As of 02:26PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 8.40M
Enterprise value 15.35M
Trailing P/E N/A
Forward P/E 21.83
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.72
Price/book (mrq)15.49
Enterprise value/revenue 1.86
Enterprise value/EBITDA -1.34

Trading information

Stock price history

Beta (5Y monthly) 1.93
52-week change 37.95%
S&P500 52-week change 323.57%
52-week high 344.56
52-week low 33.69
50-day moving average 312.39
200-day moving average 37.95

Share statistics

Avg vol (3-month) 3442.63k
Avg vol (10-day) 325.98k
Shares outstanding 51.41M
Implied shares outstanding 61.41M
Float 8718.92k
% held by insiders 124.06%
% held by institutions 14.85%
Shares short (15 Apr 2024) 420.53k
Short ratio (15 Apr 2024) 40.3
Short % of float (15 Apr 2024) 42.33%
Short % of shares outstanding (15 Apr 2024) 41.70%
Shares short (prior month 15 Mar 2024) 455.98k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 322 Mar 2024
Ex-dividend date 425 Mar 2024
Last split factor 21:15
Last split date 322 June 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -215.71%
Operating margin (ttm)-263.25%

Management effectiveness

Return on assets (ttm)-55.90%
Return on equity (ttm)-3,099.92%

Income statement

Revenue (ttm)8.27M
Revenue per share (ttm)10.83
Quarterly revenue growth (yoy)4.30%
Gross profit (ttm)N/A
EBITDA -7.24M
Net income avi to common (ttm)-13.72M
Diluted EPS (ttm)-17.96
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)151.91k
Total cash per share (mrq)0.11
Total debt (mrq)7.1M
Total debt/equity (mrq)1,309.83%
Current ratio (mrq)0.24
Book value per share (mrq)0.60

Cash flow statement

Operating cash flow (ttm)-2.07M
Levered free cash flow (ttm)-2.19M